Re-treatment of Participants With Paget's Disease Using Zoledronic Acid

NCT00740129 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Paget's Disease of the Bone

Interventions

DRUG: Zoledronic Acid

Sponsor

Novartis Pharmaceuticals